Medical News

RSS

Biostar Pharmaceuticals lists on NASDAQ Global Market

Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.

23 Apr 2010

OSI Pharmaceuticals' first-quarter 2010 total revenues increase 14% to $107M

OSI Pharmaceuticals, Inc. announced today its financial results for the first quarter ended March 31, 2010. The Company reported total revenues from continuing operations of $107 million for the first quarter of 2010, a 14% increase over revenues of $94 million for the first quarter of 2009.

23 Apr 2010

FDA grants conditional approval for first approved Total Spine Arthroplasty system clinical study

Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.

23 Apr 2010

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Pfizer Inc. announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma, or liver cancer. Following a review by the independent Data Monitoring Committee, the study was discontinued based on a higher incidence of serious adverse events in the sunitinib arm compared to the sorafenib arm and the fact that sunitinib did not meet the criteria to demonstrate that it was either superior or non-inferior to sorafenib in the survival of patients with advanced hepatocellular cancer.

23 Apr 2010

Cytori announces launch of PureGraft 250 fat grafting technology at ASAPS meeting

Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.

23 Apr 2010

Sebelius says HHS will not seek more money this year to implement health overhaul

"The Obama administration does not plan to seek additional money in next year's Health and Human Services Department budget to implement the new U.S. healthcare reform law, HHS Secretary Kathleen Sebelius said on Wednesday," Reuters reports. "Testifying before a House of Representatives Appropriations subcommittee, Sebelius said the $911 billion HHS budget request for fiscal year 2011, which begins Oct. 1, remains the same even after Congress passed the healthcare overhaul," which "included $1 billion" for implementation by HHS.

23 Apr 2010

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Boston Scientific Corporation today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures. Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents. The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires.

23 Apr 2010

Report: Wellpoint targets breast cancer patients with policy rescissions

Reuters, in an exclusive report about the insurance industry practice of rescission: "That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. Insurance companies have used the practice.

23 Apr 2010

Young workers who have trouble with sleep issues more likely to quit shiftwork: Study

Working the nightshift interferes with sleep, particularly for workers in their 30s and 40s, reports a study in the April Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

23 Apr 2010

Aragon Pharmaceuticals raises $22M through Series B financing

Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing.

23 Apr 2010

Democrats, GOP continue to trade barbs over health reform, plan next moves

Politico: Democrats are following a call from President Barack Obama in daring Republicans to try to repeal the health care reform law. "And they started with what Democrats hope will become one of the most popular features of the overhaul plan, a provision that allow young adults to stay on their parents' insurance plans until age 26.

23 Apr 2010

Molecular mechanisms of hypertension, its diagnosis and treatment to be focused at ASBMB's symposium

About 1 billion people around the world suffer from hypertension. The molecular mechanisms of this disease, its diagnosis and treatment will be the focus of a lecture series at the American Society for Biochemistry and Molecular Biology's annual meeting in Anaheim, Calif. The talks will take place from Monday, May 26 through Wednesday, April 28 in room 304C of the Anaheim Convention Center.

23 Apr 2010

Acacia Research reports record first-quarter license fee revenues of $39.77M

Acacia Research Corporation today reported results for the three months ended March 31, 2010.

23 Apr 2010

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Ampio Pharmaceuticals, Inc., today announced that it has entered into a letter of intent to acquire DMI Biosciences, Inc.

23 Apr 2010

CBO estimate: 4 million could pay health insurance penalty by 2016

The Associated Press: "Nearly 4 million Americans will have to pay a penalty if they fail to get health insurance when that element of President Barack Obama's health care overhaul law kicks in, according to congressional projections released Thursday." According to a Congressional Budget Office report, the average penalty in 2016 will be slightly more than $1,000 and the majority of people who pay the fine will be middle class.

23 Apr 2010

CRT teams up with The University of Auckland to discover novel treatments for cancer

Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.

23 Apr 2010

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).

23 Apr 2010

Website launched to track aid to Haiti from 'pledge to impact'

Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.

23 Apr 2010

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

The seasonal flu vaccine has caused serious side effects in dozens of children in Western Australia (WA) and following this the Health Department has suspended further free flu vaccinations for under-fives. There has been as rise in admissions to Princess Margaret Hospital. The side effects to the flu vaccine include fever, vomiting and often seizures related to high fever, also known as febrile convulsions. One of the children is seriously ill at present.

22 Apr 2010

Zimmer reports increase of 7.1% in net sales for first-quarter

Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2010. The Company reported first quarter net sales of $1.06 billion, an increase of 7.1% reported and 3.4% constant currency over the first quarter of 2009. Diluted earnings per share for the quarter were $1.01 reported and $1.02 adjusted, an increase of 7.4% adjusted over the prior year period.

22 Apr 2010

Medical News

Biostar Pharmaceuticals lists on NASDAQ Global Market

OSI Pharmaceuticals' first-quarter 2010 total revenues increase 14% to $107M

FDA grants conditional approval for first approved Total Spine Arthroplasty system clinical study

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Cytori announces launch of PureGraft 250 fat grafting technology at ASAPS meeting

Sebelius says HHS will not seek more money this year to implement health overhaul

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Report: Wellpoint targets breast cancer patients with policy rescissions

Young workers who have trouble with sleep issues more likely to quit shiftwork: Study

Aragon Pharmaceuticals raises $22M through Series B financing

Democrats, GOP continue to trade barbs over health reform, plan next moves

Molecular mechanisms of hypertension, its diagnosis and treatment to be focused at ASBMB's symposium

Acacia Research reports record first-quarter license fee revenues of $39.77M

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

CBO estimate: 4 million could pay health insurance penalty by 2016

CRT teams up with The University of Auckland to discover novel treatments for cancer

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Website launched to track aid to Haiti from 'pledge to impact'

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

Zimmer reports increase of 7.1% in net sales for first-quarter

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News